Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sravanthi Cheeti

5PUBLICATIONS

75CO-AUTHORS

Molecular targetsInformation systems development methodologies and practicePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 27, 2025

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Mar 27, 2024

Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.

Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk

|Mar 14, 2024

Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib.

Christine Bowman, Michael Dolton, Fang Ma

|Jun 01, 2023

An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.

Sarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo

|Oct 17, 2018

Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.

Sravanthi Cheeti, Hao Helen Hou, Eric Nelson

Pageof 1

Frequent Collaborators

2 joint publications

Jill Fredrickson

1 joint publications

Sarat Chandarlapaty

1 joint publications

Maura N Dickler

1 joint publications

Jose Alejandro Perez Fidalgo

1 joint publications

Rafael Villanueva-Vázquez

1 joint publications

Jennifer Giltnane

1 joint publications

Mary Gates

1 joint publications

Ching-Wei Chang

1 joint publications

Xiaojing Wang

1 joint publications

Ann Collier

Frequent Collaborators

2 joint publications

Jill Fredrickson

1 joint publications

Sarat Chandarlapaty

1 joint publications

Maura N Dickler

1 joint publications

Jose Alejandro Perez Fidalgo

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

Published on : May 27, 2022

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

See more related videos

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

<em>In Silico</em> Clinical Trials for Cardiovascular Disease

Published on : May 27, 2022

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

See more related videos